The World Market for Point of Care (POC) Diagnostics
Visit our 'Point of Care Testing' curated page for complete industry coverage.
Clinical diagnostic tests performed outside the central laboratory or decentralized testing are generally known as point of care (POC) diagnostic tests. The increasing introduction of transportable, portable, and handheld diagnostic instruments has resulted in the migration of point of care diagnostic testing from the hospital environment to a range of medical environments including the workplace, home, disaster care and most recently, convenience clinics.
Who are the top POC diagnostic companies in the healthcare industry? What types of point of care diagnostic testing is selling fastest? What disease areas will drive near-patient testing forward? Is point of care testing earning its place in clinical practice? How is home testing progressing? Kalorama Information's report, The World Market for Point of Care (POC) Diagnostics, presents current analysis of the point of care diagnostics industry and the role it plays in healthcare. Kalorama Information takes an in-depth look at the POC diagnostic testing market, both professional and self-testing.
Discussed Point of Care Diagnostic Testing Market Segments:
- Blood Glucose Tests
- Blood and Electrolytes Testing Market
- Rapid Coagulation
- Rapid Cardiac Markers
- Substance Abuse Testing
- Pregnancy and Fertility Testing
- Colon Cancer Screening/Fecal Occult Blood Testing
- Infectious Disease Testing
- Cholesterol Testing
- Cancer Testing
- Urine Strip Testing
- Miscellaneous POC Testing
The menu for point-of-care diagnostic testing continues to expand. The traditional set of POC tests includes: blood glucose testing, blood gas and electrolytes analysis, rapid coagulation testing, rapid cardiac markers diagnostics, drugs of abuse screening, urine strips testing, pregnancy testing, fecal occult blood analysis, hemoglobin diagnostics, infectious disease testing and cholesterol screening. In the past 5-10 years the following tests were added: HgA1c, B-Type Natriuretic Peptide (BNP), whole-blood lactate, D-Dimer, C-Reactive Protein (CRP).
Point of care diagnostic testing devices have contributed significantly to the growth of the overall diagnostics market over the past 10 years. POC testing appears to be headed for an even bigger role in diagnosis and monitoring patient care. New diagnostic technologies are allowing point of care devices to produce quantitative lab-quality test results that can be transferred automatically to an information system, a remote caregiver service for consultation or an electronic medical record.
The report’s geographic scope is worldwide with information for specific geographical regions, world demographics, and other general issues affecting the market. All market data pertain to the world market at the manufacturers’ level. The point of care diagnostic testing market includes manufacturer tests excluding services. The base year for data is 2014. Historical data is provided for the years 2012 and 2014, with forecast data provided for 2014 through 2019. Compound annual growth rates (CAGRs) are provided for 2014-2019 periods for each segment covered. Competitive analysis is provided for the year 2014.
The forecasted POC testing market analysis for 2014-2019 is largely based on demographic trends, new developments, innovative technology and global expansion.
Point of Care Diagnostic Testing Market Analysis includes:
- Market Overview
- Market Analysis by Product Categories
- Market Analysis by Subcategory: POC Professional Testing, POC Self-Testing
- Market Analysis by Country: United States, Germany, France, UK, Switzerland, Japan, China, India
- Market Conclusions
- Competitive Analysis
- The World Market for Point of Care (POC) Diagnostics presents the main issues and trends affecting this market, influencing its move into the future. These include:
- Reimbursement Challenges
- POC and Biosensors
- POC Connectivity
- The Emergence of Non-invasive Technologies
Top and/or innovative POC companies discussed within the report's Corporate Profiles:
- Abbott Labs
- Beckman Coulter
- bioMerieux SA
- Church & Dwight
- Eiken Chemical
- EKF Diagnostics
- Helena Labs
- Insight Pharmaceutical
- Instrumentation Laboratories
- Meridian BioScience
- Nova Biomedical
- OPKO Health
- Ortho Clinical Diagnostics
- Polymed Therapeutics
- Polymer Technologies
- Radiometer Medical
- Response Biomedical
- Roche Diagnostics
- Siemens Healthcare
- Trinity Biotech
The information for this report was gathered using both primary and secondary research including comprehensive research of secondary sources such as company literature, databases, investment reports, and medical and business journals. Telephone interviews and email correspondence were the primary method of gathering information. For the purpose of this study, Kalorama Information conducted interviews with more than 30 key industry officials, consultants, health care providers, and government personnel. These sources were the primary basis in gathering information specifically relating to revenue and market share data presented in this report. Additional interviews were completed with relevant company representatives including marketing directors, division managers, and product representatives.